Trial · NCT02654678
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of patients with Adverse Reactions | up to month 10 | Adverse Reaction definition according to European Directive 2001/20/EC, assessed at each Visit concerning intensity and causality |
| Secondary | Blood pressure | At every Visit: (day 0, month 1, 4, 7, 10) | Measurement pre-dose after 5 minutes at rest at every Visit up to end of treatment at Month 10 |
| Secondary | Renin | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Renin to assess the Renin-angiotensin-aldosterone system (RAAS) measured at every Visit up to end of treatment at Month 10 |
| Secondary | Angiotensin 1 | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Angiotensin 1to assess the Renin-angiotensin-aldosterone system (RAAS) measured at every Visit up to end of treatment at Month 10 |
| Secondary | Aldosterone | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Aldosterone to assess the Renin-angiotensin-aldosterone system (RAAS) measured at every Visit up to end of treatment at Month 10 |
| Secondary | Plasma Renin Activity | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Plasma renin activity to assess the Renin-angiotensin-aldosterone system (RAAS) measured at every Visit up to end of treatment at Month 10 |
| Secondary | Creatinine | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Creatinine for renal monitoring measured at every Visit up to end of treatment at Month 10 |
| Secondary | Urea nitrogen | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Urea nitrogen for renal monitoring measured at every Visit up to end of treatment at Month 10 |
| Secondary | Serum potassium | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Serum potassium for renal monitoring measured at every Visit up to end of treatment at Month 10 |
| Secondary | Brain-Natriuretic-Peptides (BNP) | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | BNP measured at every visit up to end of treatment at Month 10 to observe disease severity |
| Secondary | Micro-albuminuria | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | Measurement of micro-albuminuria for renal monitoring measured at every Visit up to end of treatment at Month 10 |
| Secondary | Clinical haematology | Day 0 and Month 10 | Assessment at First and Last Study Visit at the end of treatment at Month 10 |
| Secondary | ECG | Day 0 and Month 10 | Assessment at First and Last Study Visit at the end of treatment at Month 10 |
| Secondary | Plasma concentration of enalapril and its active metabolite enalaprilat under long-term treatment | Pre-dose at each Visit: (day 0, month 1, 4, 7, 10) | At each Visit in children under enalapril ODMT treatment a single blood sample will be collected to measure the enalapril and enalaprilat plasma levels during long-term treatment; population-kinetic investigation |
| Secondary | Acceptability assessment of enalapril ODMTs | At each Visit: (day 0, month 1, 4, 7, 10) | Acceptability assessment at each Visit up to end of treatment at 10 months in children under enalapril ODMT treatment according to an age-appropriate scale |
| Secondary | Palatability assessment of enalapril ODMTs | At each Visit: (day 0, month 1, 4, 7, 10) | Palatability assessment at each Visit up to end of treatment at Month 10 in children under enalapril ODMT treatment according to an age-appropriate scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02654678/registered